Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Br J Haematol. 2015 Jul 24;171(4):471–477. doi: 10.1111/bjh.13607

Table III.

Grade 3–5 adverse events.

Adverse event Grade 3 (%) Grade 4 (%) Grade 5 (%) Grade 3–5 (%)
Infection 3 (21) 0 0 3 (21)
Febrile neutropenia 2 (14) 0 0 2 (14)
Neutropenia 0 2 (14) 0 2 (14)
Syncope 2 (14) 0 0 2 (14)
Hypotension 2 (14) 0 0 2 (14)
Hypertension 1 (7) 0 0 1 (7)
Angina pectoris 1 (7) 0 0 1 (7)
Atrial fibrillation 1 (7) 0 0 1 (7)
PML 1 (7) 0 0 1 (7)
Haemorrhage 0 0 1 (7) 1 (7)
Decreased LOC 1 (7) 0 0 1 (7)
Thrombocytosis 0 1 (7) 0 1 (7)
Thrombocytopenia 1 (7) 0 0 1 (7)
Hypophosphataemia 1 (7) 0 0 1 (7)

LOC, level of consciousness; PML, progressive multifocal leucoencephalopathy.